Earnings ·
Profound Medical reports Q3 revenue of $9.8M and announces CEO succession for Jan 2027
PROFProfound Medical Corp.
Profound Medical reported third-quarter 2026 revenue of approximately $9.8 million, an 86% increase year-over-year, driven by $5.7 million in capital equipment sales and $4.1 million in recurring non-capital revenue. Gross margin expanded to 78%, while operating cash used declined 56% sequentially to $5.0 million. The company projects full-year 2026 revenue of at least $25.0 million with gross margins of 70% or higher. Additionally, Profound announced that Richard Fabian will succeed Arun Menawat as CEO effective January 14, 2027, while Menawat transitions to Executive Chairman and Matthew Sobczyk becomes permanent CFO.